Calcitriol Treatment in Metabolic Bone Disease of Prematurity with Elevated Parathyroid Hormone: A Preliminary Study

Conclusion Improvements in MBD markers and lack of serious adverse effects suggest calcitriol may be a treatment option in infants with MBD and secondary hyperparathyroidism.
Source: Journal of Clinical and Translational Endocrinology - Category: Endocrinology Source Type: research